NICE advice and quality standards: Interventional procedures guidance - Nivolumab with chemotherapy for neoadjuvant treatment of resectable non-small-cell lung cancer

NICE (National Institute for Health and Care Excellence) pubblished on 22 March 2023 the Interventional procedures guidance on Nivolumab:

Nivolumab with chemotherapy for neoadjuvant treatment of resectable non-small-cell lung cancer. full guidance available here